Pharmaceuticals - Bahrain

Bahrain

The Pharmaceuticals market in Bahrain is expected to witness significant growth in the coming years.
According to projections, the revenue in this market is estimated to reach US$159.80m in 2024.
Among the various markets, Oncology Drugs is anticipated to be the largest, with a projected market volume of US$30.70m in the same year.
Furthermore, the Pharmaceuticals market in Bahrain is expected to exhibit a steady annual growth rate of 6.46% from 2024 to 2028.
This growth is projected to result in a market volume of US$205.30m by 2028.
In terms of global comparison, United States is poised to generate the highest revenue in the Pharmaceuticals market.
In 2024 alone, United States is projected to generate a staggering US$636.90bn in revenue.
These figures highlight the immense potential and importance of the Pharmaceuticals market in Bahrain, as well as its substantial contribution to the global pharmaceutical industry.
The pharmaceutical market in Bahrain has witnessed a surge in demand for generic drugs, driven by increasing healthcare costs and government initiatives to promote affordable healthcare.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Bahrain has been evolving over the years, driven by global trends and local factors.

Customer preferences: Bahrain has a high demand for pharmaceutical products due to its growing population and the increasing prevalence of chronic diseases. Patients in Bahrain prefer branded drugs over generic alternatives, which is a trend observed in many other countries in the region. Additionally, the government's healthcare policy provides universal healthcare coverage to all citizens and residents, which has contributed to the growth of the pharmaceutical market.

Trends in the market: The pharmaceutical market in Bahrain is expected to grow at a steady pace, driven by factors such as an aging population, increasing healthcare expenditure, and the rising prevalence of chronic diseases. The government's efforts to improve the healthcare infrastructure and attract foreign investment in the sector are also expected to contribute to the growth of the market. Additionally, the increasing focus on research and development in the pharmaceutical industry is expected to lead to the introduction of innovative drugs in the market.

Local special circumstances: Bahrain has a small domestic market, which has led to the government's efforts to attract foreign investment in the pharmaceutical sector. The Bahrain Economic Development Board has been actively promoting the country as a hub for healthcare and life sciences, offering incentives such as tax exemptions and streamlined regulatory processes. Additionally, the country's strategic location and well-developed infrastructure make it an attractive destination for pharmaceutical companies looking to expand their operations in the region.

Underlying macroeconomic factors: Bahrain's economy is heavily dependent on the oil and gas sector, which has been facing challenges in recent years due to the global drop in oil prices. However, the government has been implementing economic diversification initiatives to reduce the country's reliance on oil revenues. The pharmaceutical industry is one of the sectors identified for growth under these initiatives, which is expected to provide opportunities for local and foreign investors. Additionally, Bahrain's stable political environment and business-friendly policies make it an attractive destination for foreign investment.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.